The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
about
The burden and management of cytochrome P450 2D6 (CYP2D6)-mediated drug-drug interaction (DDI): co-medication of metoprolol and paroxetine or fluoxetine in the elderly.Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.Quantitative prediction of cytochrome P450 (CYP) 2D6-mediated drug interactions.Direct and quantitative evaluation of the major human CYP contribution (fmCYP) to drug clearance using the in vitro Silensomes™ model.Inhibitory Effect of Citalopram on the Pharmacokinetics of Carvedilol in Rats and in vitro Models.Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
P2860
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@ast
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@en
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@nl
type
label
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@ast
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@en
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@nl
prefLabel
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@ast
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@en
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics.
@nl
P2093
P2860
P356
P1476
The impact of paroxetine coadministration on stereospecific carvedilol pharmacokinetics
@en
P2093
Barry E Bleske
Jace Nielsen
Kevin Kerber
Michael Shea
Robert Brook
Stephen M Stout
P2860
P304
P356
10.1177/1074248410372926
P577
2010-08-12T00:00:00Z